Z Kecskes1, D W Cartwright. 1. Royal Children's Hospital Foundation, Royal Children's Hospital, Herston Road, Herston, Queensland, Australia. zsuzsoka.kecskes@act.gov.au
Abstract
OBJECTIVE: To evaluate incidence and mortality of congenital heart disease in very low birthweight babies. METHOD: Retrospective analysis of a 12 year period. RESULTS: Forty seven babies were diagnosed with severe congenital heart disease. The most common lesions were ventricular septal defect and coarctation of the aorta. Mortality attributed to congenital heart disease was 32%. Coarctation of the aorta, the second most common lesion, was fatal in 62% of cases. Closure of a patent ductus arteriosus with indomethacin proved to be detrimental in babies with undiagnosed coarctation, causing rapid deterioration in some. CONCLUSION: Very low birthweight neonates with severe congenital heart disease have a higher mortality than babies with higher birth weight. A contributing factor is closure of a patent ductus arteriosus if an underlying lesion has not been recognised. This could be of significance if the use of prophylactic treatment with indomethacin becomes more common.
OBJECTIVE: To evaluate incidence and mortality of congenital heart disease in very low birthweight babies. METHOD: Retrospective analysis of a 12 year period. RESULTS: Forty seven babies were diagnosed with severe congenital heart disease. The most common lesions were ventricular septal defect and coarctation of the aorta. Mortality attributed to congenital heart disease was 32%. Coarctation of the aorta, the second most common lesion, was fatal in 62% of cases. Closure of a patent ductus arteriosus with indomethacin proved to be detrimental in babies with undiagnosed coarctation, causing rapid deterioration in some. CONCLUSION: Very low birthweight neonates with severe congenital heart disease have a higher mortality than babies with higher birth weight. A contributing factor is closure of a patent ductus arteriosus if an underlying lesion has not been recognised. This could be of significance if the use of prophylactic treatment with indomethacin becomes more common.
Authors: B Schmidt; P Davis; D Moddemann; A Ohlsson; R S Roberts; S Saigal; A Solimano; M Vincer; L L Wright Journal: N Engl J Med Date: 2001-06-28 Impact factor: 91.245
Authors: L R Ment; W Oh; R A Ehrenkranz; A G Philip; B Vohr; W Allan; C C Duncan; D T Scott; K J Taylor; K H Katz Journal: Pediatrics Date: 1994-04 Impact factor: 7.124
Authors: L D Allan; G K Sharland; A Milburn; S M Lockhart; A M Groves; R H Anderson; A C Cook; N L Fagg Journal: J Am Coll Cardiol Date: 1994-05 Impact factor: 24.094
Authors: Angelo Polito; Simone Piga; Paola E Cogo; Carlo Corchia; Virgilio Carnielli; Monica Da Frè; Domenico Di Lallo; Isabella Favia; Luigi Gagliardi; Francesco Macagno; Silvana Miniaci; Marina Cuttini Journal: Intensive Care Med Date: 2013-03-28 Impact factor: 17.440
Authors: Wendy N Nembhard; Jason L Salemi; Melissa L Loscalzo; Tao Wang; Kimberlea W Hauser Journal: Pediatr Cardiol Date: 2009-05-02 Impact factor: 1.655
Authors: Mikael Norman; Stellan Håkansson; Satoshi Kusuda; Maximo Vento; Liisa Lehtonen; Brian Reichman; Brian A Darlow; Mark Adams; Dirk Bassler; Tetsuya Isayama; Franca Rusconi; Shoo Lee; Kei Lui; Junmin Yang; Prakesh S Shah Journal: J Am Heart Assoc Date: 2020-02-21 Impact factor: 5.501
Authors: Elza Cloete; Frank H Bloomfield; Sharnie A Cassells; Monique W M de Laat; Lynn Sadler; Thomas L Gentles Journal: Acta Paediatr Date: 2019-09-02 Impact factor: 2.299
Authors: Woo Sun Song; Chae Young Kim; Byong Sop Lee; Ellen Ai Rhan Kim; Ki Soo Kim; Euiseok Jung Journal: Korean Circ J Date: 2020-12 Impact factor: 3.243